- Home
- HI vs NVCR Comparison
HI vs NVCR Comparison
Compare HI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HI
- NVCR
- Stock Information
- Founded
- HI 2007
- NVCR 2000
- Country
- HI United States
- NVCR Switzerland
- Employees
- HI N/A
- NVCR N/A
- Industry
- HI Miscellaneous manufacturing industries
- NVCR Medical/Dental Instruments
- Sector
- HI Consumer Discretionary
- NVCR Health Care
- Exchange
- HI Nasdaq
- NVCR Nasdaq
- Market Cap
- HI 1.6B
- NVCR 1.4B
- IPO Year
- HI N/A
- NVCR 2015
- Fundamental
- Price
- HI $25.57
- NVCR $11.54
- Analyst Decision
- HI Hold
- NVCR Buy
- Analyst Count
- HI 2
- NVCR 7
- Target Price
- HI $24.00
- NVCR $28.79
- AVG Volume (30 Days)
- HI 613.1K
- NVCR 2.2M
- Earning Date
- HI 08-11-2025
- NVCR 07-24-2025
- Dividend Yield
- HI 3.52%
- NVCR N/A
- EPS Growth
- HI N/A
- NVCR N/A
- EPS
- HI N/A
- NVCR N/A
- Revenue
- HI $2,859,300,000.00
- NVCR $630,160,000.00
- Revenue This Year
- HI N/A
- NVCR $6.15
- Revenue Next Year
- HI N/A
- NVCR $7.35
- P/E Ratio
- HI N/A
- NVCR N/A
- Revenue Growth
- HI N/A
- NVCR 14.58
- 52 Week Low
- HI $18.36
- NVCR $10.87
- 52 Week High
- HI $35.59
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- HI 68.05
- NVCR 32.75
- Support Level
- HI $19.32
- NVCR $10.87
- Resistance Level
- HI $27.08
- NVCR $11.99
- Average True Range (ATR)
- HI 1.17
- NVCR 0.57
- MACD
- HI 0.55
- NVCR 0.10
- Stochastic Oscillator
- HI 80.64
- NVCR 25.17
About HI Hillenbrand Inc
Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.